Lipohypertrophy in acromegaly induced by the new growth hormone receptor antagonist pegvisomant

Ann Intern Med. 2006 Aug 15;145(4):310-2. doi: 10.7326/0003-4819-145-4-200608150-00017.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Abdomen
  • Acromegaly / drug therapy*
  • Adipose Tissue / pathology*
  • Adult
  • Female
  • Human Growth Hormone / administration & dosage
  • Human Growth Hormone / adverse effects
  • Human Growth Hormone / analogs & derivatives*
  • Humans
  • Hypertrophy
  • Injections, Subcutaneous / adverse effects
  • Lipodystrophy / chemically induced*
  • Male

Substances

  • Human Growth Hormone
  • pegvisomant